Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Identifying and characterizing novel antifungal compounds to combat azole resistance in the human fungal pathogen Candida albicans

EF 2019-20

Résumé
"Candida albicans is the leading cause of invasive fungal disease in humans, which are associated with global mortality rates comparable to those of tuberculosis and HIV. Effective treatment of these deadly infections is threatened by the unprecedented emergence of antifungal drug resistance, given the limited number of antifungal drug classes available. As such, there is an urgent need for novel therapeutic strategies. In addition to discovering new drug targets, a promising approach to overcome antifungal resistance is developing combination therapies which can improve the efficacy of widely used clinical antifungals such as the azoles. Our lab recently identified six novel chemical agents with potent effects against drug-sensitive C. albicans. The goal of my research is to characterize the activity and therapeutic potential of these compounds against azole-resistant C. albicans, as single agents and in combination with known antifungals. I will perform experiments to evaluate growth inhibition and cidality, as well as to define human cell toxicity and fungal selectivity. Moreover, I will employ global chemical-genetic profiling to elucidate the target genes and mechanism of action of these compounds. I will additionally conduct selection experiments and biochemical analyses to further uncover how target inhibition by these compounds influences the evolution of antifungal drug resistance. My project will contribute to increasing the antifungal repertoire and provide insights to enable new treatment strategies against drug- resistant, life-threatening fungal infections."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
429098
Name
Xue Alice
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying and characterizing novel antifungal compounds to combat azole resistance in the human fungal pathogen Candida albicans
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antifungal Drug Resistance; Candida; Chemical Genetics; Fungal Pathogens; Infectious Disease; Microbial Genomics
Abstract
"Candida albicans is the leading cause of invasive fungal disease in humans, which are associated with global mortality rates comparable to those of tuberculosis and HIV. Effective treatment of these deadly infections is threatened by the unprecedented emergence of antifungal drug resistance, given the limited number of antifungal drug classes available. As such, there is an urgent need for novel therapeutic strategies. In addition to discovering new drug targets, a promising approach to overcome antifungal resistance is developing combination therapies which can improve the efficacy of widely used clinical antifungals such as the azoles. Our lab recently identified six novel chemical agents with potent effects against drug-sensitive C. albicans. The goal of my research is to characterize the activity and therapeutic potential of these compounds against azole-resistant C. albicans, as single agents and in combination with known antifungals. I will perform experiments to evaluate growth inhibition and cidality, as well as to define human cell toxicity and fungal selectivity. Moreover, I will employ global chemical-genetic profiling to elucidate the target genes and mechanism of action of these compounds. I will additionally conduct selection experiments and biochemical analyses to further uncover how target inhibition by these compounds influences the evolution of antifungal drug resistance. My project will contribute to increasing the antifungal repertoire and provide insights to enable new treatment strategies against drug- resistant, life-threatening fungal infections."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Xue, Alice
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~